JPS53101515A - Medicine having anodyne * sedative and antiallergic activity and production thereof - Google Patents

Medicine having anodyne * sedative and antiallergic activity and production thereof

Info

Publication number
JPS53101515A
JPS53101515A JP1649877A JP1649877A JPS53101515A JP S53101515 A JPS53101515 A JP S53101515A JP 1649877 A JP1649877 A JP 1649877A JP 1649877 A JP1649877 A JP 1649877A JP S53101515 A JPS53101515 A JP S53101515A
Authority
JP
Japan
Prior art keywords
anodyne
sedative
medicine
production
antiallergic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1649877A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6339572B2 (enrdf_load_stackoverflow
Inventor
Jinemon Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11917938&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS53101515(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Priority to JP1649877A priority Critical patent/JPS53101515A/ja
Publication of JPS53101515A publication Critical patent/JPS53101515A/ja
Publication of JPS6339572B2 publication Critical patent/JPS6339572B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP1649877A 1977-02-17 1977-02-17 Medicine having anodyne * sedative and antiallergic activity and production thereof Granted JPS53101515A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1649877A JPS53101515A (en) 1977-02-17 1977-02-17 Medicine having anodyne * sedative and antiallergic activity and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1649877A JPS53101515A (en) 1977-02-17 1977-02-17 Medicine having anodyne * sedative and antiallergic activity and production thereof

Publications (2)

Publication Number Publication Date
JPS53101515A true JPS53101515A (en) 1978-09-05
JPS6339572B2 JPS6339572B2 (enrdf_load_stackoverflow) 1988-08-05

Family

ID=11917938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1649877A Granted JPS53101515A (en) 1977-02-17 1977-02-17 Medicine having anodyne * sedative and antiallergic activity and production thereof

Country Status (1)

Country Link
JP (1) JPS53101515A (enrdf_load_stackoverflow)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質
US5013558A (en) * 1988-06-20 1991-05-07 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical treatments for cerebral and neuronal diseases
US5057324A (en) * 1987-07-23 1991-10-15 Nippon Zoki Pharmaceutical Co., Ltd. Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
US5534509A (en) * 1993-03-19 1996-07-09 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition regulating function of a living body
US5560935A (en) * 1993-09-28 1996-10-01 Nippon Zoki Pharmaceutical Co., Ltd. Physiologically active substances extracted from activated tissues
US5599683A (en) * 1993-08-06 1997-02-04 Nippon Zoki Pharmaceutical Co., Ltd. Method for measuring production activity of test substance towards FXIIa
US5648228A (en) * 1993-08-06 1997-07-15 Nippon Zoki Pharmaceutical Co., Ltd. Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system
EP0852950A1 (en) * 1997-01-08 1998-07-15 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
US6165515A (en) * 1997-09-12 2000-12-26 Nippon Zoki Pharmaceutical Co., Ltd. Method for treatment of osteoporosis
US6365192B1 (en) 1999-04-15 2002-04-02 Nippon Zoki Pharmaceutical Co., Ltd. Bioactivating substance
US6541041B1 (en) 1997-11-28 2003-04-01 Nippon Zoki Pharmaceutical Co., Ltd. Crude drug extracts, and methods for making and standardizing same
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
WO2004039383A1 (ja) * 2002-10-31 2004-05-13 Nippon Zoki Pharmaceutical Co., Ltd. 線維筋痛症治療剤
US6913900B2 (en) 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
WO2007114230A1 (ja) 2006-03-30 2007-10-11 Kyoto University チオレドキシン産生促進剤
WO2009028605A1 (ja) 2007-08-31 2009-03-05 Kyushu University, National University Corporation 抗がん剤による末梢神経障害の予防又は軽減剤
WO2011111770A1 (ja) 2010-03-11 2011-09-15 日本臓器製薬株式会社 慢性前立腺炎、間質性膀胱炎及び／又は排尿障害の改善又は治療剤
WO2011162317A1 (ja) 2010-06-25 2011-12-29 日本臓器製薬株式会社 被検物質の判定又は評価方法
US8293280B2 (en) 2004-12-17 2012-10-23 Nippon Zoki Pharmaceutical Co., Ltd. Method for treatment of HIV infection
US8568789B2 (en) 2004-12-01 2013-10-29 Nippon Zoki Pharmaceutical Co., Ltd. Dried product and a process for manufacturing the product
WO2013173941A1 (en) * 2012-05-25 2013-11-28 Well Resources Limited Peptide and the use thereof
JP2014209129A (ja) * 2006-09-06 2014-11-06 日本臓器製薬株式会社 被検物質の評価方法
WO2017146230A1 (ja) * 2016-02-24 2017-08-31 国立大学法人大阪大学 試験方法
US9884077B2 (en) 2013-04-30 2018-02-06 Nippon Zoki Pharmaceutical Co., Ltd. Extract and preparation containing said extract
JP2018048129A (ja) * 2016-09-14 2018-03-29 日本臓器製薬株式会社 肢端紅痛症の改善又は治療剤
KR20180104049A (ko) 2016-01-29 2018-09-19 고쿠리츠 다이가쿠 호우징 지바 다이가쿠 근손상의 예방 또는 치료제
US10711292B2 (en) 2010-10-14 2020-07-14 Nikkon Zoki Pharmaceutical Co., Ltd. Method for promoting the synthesis of collagen and proteoglycan in chondrocytes
US11207354B2 (en) 2016-09-23 2021-12-28 Osaka University Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質
US5057324A (en) * 1987-07-23 1991-10-15 Nippon Zoki Pharmaceutical Co., Ltd. Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
US5013558A (en) * 1988-06-20 1991-05-07 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical treatments for cerebral and neuronal diseases
US5658896A (en) * 1993-03-19 1997-08-19 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition regulating function of a living body
US5534509A (en) * 1993-03-19 1996-07-09 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition regulating function of a living body
US5807951A (en) * 1993-03-19 1998-09-15 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition regulating function of a living body
US5599683A (en) * 1993-08-06 1997-02-04 Nippon Zoki Pharmaceutical Co., Ltd. Method for measuring production activity of test substance towards FXIIa
US5648228A (en) * 1993-08-06 1997-07-15 Nippon Zoki Pharmaceutical Co., Ltd. Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system
US5560935A (en) * 1993-09-28 1996-10-01 Nippon Zoki Pharmaceutical Co., Ltd. Physiologically active substances extracted from activated tissues
EP0852950A1 (en) * 1997-01-08 1998-07-15 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
US6051613A (en) * 1997-01-08 2000-04-18 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
US6165515A (en) * 1997-09-12 2000-12-26 Nippon Zoki Pharmaceutical Co., Ltd. Method for treatment of osteoporosis
US6541041B1 (en) 1997-11-28 2003-04-01 Nippon Zoki Pharmaceutical Co., Ltd. Crude drug extracts, and methods for making and standardizing same
US6576241B2 (en) 1997-11-28 2003-06-10 Nippon Zoki Pharmaceutical Co., Ltd. Crude drug extracts, and methods for making and standardizing same
US6365192B1 (en) 1999-04-15 2002-04-02 Nippon Zoki Pharmaceutical Co., Ltd. Bioactivating substance
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
US6913900B2 (en) 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
US7435547B2 (en) 2002-10-31 2008-10-14 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for fibromyalgia
US7238487B2 (en) 2002-10-31 2007-07-03 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for fibromyalgia
WO2004039383A1 (ja) * 2002-10-31 2004-05-13 Nippon Zoki Pharmaceutical Co., Ltd. 線維筋痛症治療剤
AU2003280684B2 (en) * 2002-10-31 2009-06-25 Nippon Zoki Pharmaceutical Co., Ltd. Remedy for fibromyalgia
US7148012B2 (en) 2002-10-31 2006-12-12 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for fibromyalgia
US8568789B2 (en) 2004-12-01 2013-10-29 Nippon Zoki Pharmaceutical Co., Ltd. Dried product and a process for manufacturing the product
US8293280B2 (en) 2004-12-17 2012-10-23 Nippon Zoki Pharmaceutical Co., Ltd. Method for treatment of HIV infection
WO2007114230A1 (ja) 2006-03-30 2007-10-11 Kyoto University チオレドキシン産生促進剤
US8338108B2 (en) 2006-03-30 2012-12-25 Kyoto University Agent for promoting the production of thioredoxin
JP2014209129A (ja) * 2006-09-06 2014-11-06 日本臓器製薬株式会社 被検物質の評価方法
WO2009028605A1 (ja) 2007-08-31 2009-03-05 Kyushu University, National University Corporation 抗がん剤による末梢神経障害の予防又は軽減剤
US8613962B2 (en) 2007-08-31 2013-12-24 Kyushu University, National University Corporation Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
WO2011111770A1 (ja) 2010-03-11 2011-09-15 日本臓器製薬株式会社 慢性前立腺炎、間質性膀胱炎及び／又は排尿障害の改善又は治療剤
CN102791277B (zh) * 2010-03-11 2016-05-04 日本脏器制药株式会社 慢性前列腺炎、间质性膀胱炎和／或排尿障碍的改善或治疗剂
CN102791277A (zh) * 2010-03-11 2012-11-21 日本脏器制药株式会社 慢性前列腺炎、间质性膀胱炎和/或排尿障碍的改善或治疗剂
US9011849B2 (en) 2010-03-11 2015-04-21 Nippon Zoki Pharmaceutical Co., Ltd. Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders
WO2011162317A1 (ja) 2010-06-25 2011-12-29 日本臓器製薬株式会社 被検物質の判定又は評価方法
US9447466B2 (en) 2010-06-25 2016-09-20 Nippon Zoki Pharmaceutical Co., Ltd. Method for determination or evaluation of test substance
US10711292B2 (en) 2010-10-14 2020-07-14 Nikkon Zoki Pharmaceutical Co., Ltd. Method for promoting the synthesis of collagen and proteoglycan in chondrocytes
WO2013173941A1 (en) * 2012-05-25 2013-11-28 Well Resources Limited Peptide and the use thereof
US9422336B2 (en) 2012-05-25 2016-08-23 Well Resources Limited Peptide for treatment of disease or symptoms associated with pain
US9839666B2 (en) 2012-05-25 2017-12-12 Wells Resources Limited Peptide and a use thereof
US9884077B2 (en) 2013-04-30 2018-02-06 Nippon Zoki Pharmaceutical Co., Ltd. Extract and preparation containing said extract
KR20180104049A (ko) 2016-01-29 2018-09-19 고쿠리츠 다이가쿠 호우징 지바 다이가쿠 근손상의 예방 또는 치료제
WO2017146230A1 (ja) * 2016-02-24 2017-08-31 国立大学法人大阪大学 試験方法
JPWO2017146230A1 (ja) * 2016-02-24 2019-02-14 国立大学法人大阪大学 試験方法
US11129976B2 (en) 2016-02-24 2021-09-28 Osaka University Test method
JP2018048129A (ja) * 2016-09-14 2018-03-29 日本臓器製薬株式会社 肢端紅痛症の改善又は治療剤
US11207354B2 (en) 2016-09-23 2021-12-28 Osaka University Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent

Also Published As

Publication number Publication date
JPS6339572B2 (enrdf_load_stackoverflow) 1988-08-05

Similar Documents

Publication Publication Date Title
JPS53101515A (en) Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS567714A (en) Pharmaceutical medicine
PH16364A (en) 1-(3-amino-2-hydroxypropyl)-2-nitroimidazole derivatives and pharmaceutical preparation
JPS5463047A (en) Novel acylanilide*its manufacture and pharmaceutical or veternary composition having antiandrogen activity
JPS5555113A (en) Oral administration medical tablet and its manufacture
DE2862017D1 (en) Xanthine derivatives having antiallergic activity and pharmacological preparations containing them
GB2073589B (en) Diagnostic and therapeutic radio pharmaceutical capsules
JPS5636481A (en) Aminopiperidine* its manufacture* intermediate and medicine
JPS5618982A (en) Pyrimidine derivatives and medicinal drug containing them
ZA784129B (en) New polyether compounds,their production and their medicinal use
GB2000027A (en) Medicine possessing antianxiety neurosis and anti-anxietylike neurosis activity
GB2103927B (en) Sub-dermal drug implants and their production
GB2006774B (en) Deoxy-narasin antibioticx their production and use
ZA784683B (en) Pseudotrisaccharides,their production and their medicinal use
JPS53145905A (en) Pharmaceutical composition and production thereof
GB2075342B (en) Sedative drug
JPS5490172A (en) Substituted 11phenyll22pyrrolidinii22yll ethanol*its manufacture and drug having analgesic activity*containing it
JPS56131509A (en) Agricultural drug and manufacture
JPS53104736A (en) Drug having pharmacological and 1 or antiibacterial activity
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
JPS5726681A (en) Substituted 2-cyclopropyl-chromone, manufacture and antiallergic pharmaceutical composition
JPS5444659A (en) Novel medicine based on 22benzylidenee33 benzofuranon*novel 22benzylidinee33benzofuranon and their manufacture
JPS54109999A (en) Novel purine derivative*its manufacture and drug containing it and having antiallergic* antiiinflammatory and antiedematous activity
ZA796294B (en) Pharmaceutical compositions with central depressant and antipsychotic activity
JPS5444684A (en) 11*55fluorouracill1**2*55diiooacetyllbetaa ddglucofuranulonoo6*33lactone and anticancer having its main activity

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term